3 January 2012 - US biopharmaceutical firm Novavax Inc (NASDAQ:NVAX) today announced that its Indian joint venture with Cadila Pharmaceuticals Ltd is getting ready to launch clinical studies of influenza and rabies vaccine candidates in 2012 and 2013, respectively.

The JV, called CPL Biolog...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up